Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Thrombosis Research
|
November 26, 2009
Underuse of evidence-based warfarin dosing methods for atrial fibrillation patients
Robby Nieuwlaat, Lucy Barker, Yang-Ki Kim, et al.
The American Journal of Psychiatry
|
June 7, 2023
Disparities in Suicide-Related Behaviors Across Sexual Orientations by Gender: A Retrospective Cohort Study Using Linked Health Administrative Data
Antony Chum, Chungah Kim, Andrew Nielsen, et al.
Journal of Veterinary Internal Medicine
|
May 6, 2021
Resting and postprandial serum bile acid concentrations in dogs with liver disease
Jorge Pena-Ramos, Lucy Barker, Rocío Saiz, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
January 10, 2012
BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines
Rachel J Davies, Alan M Holmes, John Deighton, et al.
Circulation
|
August 18, 2010
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension
Elaine Soon, Alan M Holmes, Carmen M Treacy, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)
|
August 8, 2025
Update on pediatric cataract surgery
I Christopher Lloyd, M Edward Wilson, Rupal H Trivedi, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 14, 2009
7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists
David A Sandham, Claire Adcock, Kamlesh Bala, et al.
ACS Medicinal Chemistry Letters
|
September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"
David A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma
David A Sandham, Lucy Barker, Lyndon Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 29, 2007
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists
David A Sandham, Clive Aldcroft, Urs Baettig, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Thrombosis Research
|
November 26, 2009
Underuse of evidence-based warfarin dosing methods for atrial fibrillation patients
Robby Nieuwlaat, Lucy Barker, Yang-Ki Kim, et al.
The American Journal of Psychiatry
|
June 7, 2023
Disparities in Suicide-Related Behaviors Across Sexual Orientations by Gender: A Retrospective Cohort Study Using Linked Health Administrative Data
Antony Chum, Chungah Kim, Andrew Nielsen, et al.
Journal of Veterinary Internal Medicine
|
May 6, 2021
Resting and postprandial serum bile acid concentrations in dogs with liver disease
Jorge Pena-Ramos, Lucy Barker, Rocío Saiz, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
January 10, 2012
BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines
Rachel J Davies, Alan M Holmes, John Deighton, et al.
Circulation
|
August 18, 2010
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension
Elaine Soon, Alan M Holmes, Carmen M Treacy, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)
|
August 8, 2025
Update on pediatric cataract surgery
I Christopher Lloyd, M Edward Wilson, Rupal H Trivedi, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 14, 2009
7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists
David A Sandham, Claire Adcock, Kamlesh Bala, et al.
ACS Medicinal Chemistry Letters
|
September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"
David A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma
David A Sandham, Lucy Barker, Lyndon Brown, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 29, 2007
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists
David A Sandham, Clive Aldcroft, Urs Baettig, et al.
Page
of 3